Drug companies rack up profits at expense of customers, competition
In contrast to the sickly Ukrainian economy, many of the country’s pharmaceutical companies are making healthy profits.
Ukraine’s top pharmaceutical producer, Farmak, recently reported that it had almost doubled profits in 2015 compared to 2014, and in March the company announced a 61-percent increase in dividend payments to shareholders.
Likewise, Darnytsa – Ukraine’s second biggest drug manufacturer – announced on April 25 that it had increased its revenues by 34 percent in the first quarter, and had earned a total of Hr 519 million ($20 million) thus far in 2016. According to the Ukrainian State Statistics Service, the overall output of the domestic drug indus-
Workers produce insulin at an Indar factory in Kyiv on March 13, 2013. Indar is one of the biggest producers of the drug in Ukraine. (UNIAN)